308 related articles for article (PubMed ID: 37217281)
21. CRISPR/Cas9 in Cancer Immunotherapy: Animal Models and Human Clinical Trials.
Khalaf K; Janowicz K; Dyszkiewicz-Konwińska M; Hutchings G; Dompe C; Moncrieff L; Jankowski M; Machnik M; Oleksiewicz U; Kocherova I; Petitte J; Mozdziak P; Shibli JA; Iżycki D; Józkowiak M; Piotrowska-Kempisty H; Skowroński MT; Antosik P; Kempisty B
Genes (Basel); 2020 Aug; 11(8):. PubMed ID: 32796761
[TBL] [Abstract][Full Text] [Related]
22. Modeling Breast Cancer via an Intraductal Injection of Cre-expressing Adenovirus into the Mouse Mammary Gland.
Xiang D; Tao L; Li Z
J Vis Exp; 2019 Jun; (148):. PubMed ID: 31233030
[TBL] [Abstract][Full Text] [Related]
23. CRISPR-Cas9 knockin mice for genome editing and cancer modeling.
Platt RJ; Chen S; Zhou Y; Yim MJ; Swiech L; Kempton HR; Dahlman JE; Parnas O; Eisenhaure TM; Jovanovic M; Graham DB; Jhunjhunwala S; Heidenreich M; Xavier RJ; Langer R; Anderson DG; Hacohen N; Regev A; Feng G; Sharp PA; Zhang F
Cell; 2014 Oct; 159(2):440-55. PubMed ID: 25263330
[TBL] [Abstract][Full Text] [Related]
24. Accelerating cancer modeling with RNAi and nongermline genetically engineered mouse models.
Livshits G; Lowe SW
Cold Spring Harb Protoc; 2013 Nov; 2013(11):. PubMed ID: 24184755
[TBL] [Abstract][Full Text] [Related]
25. Genotyping Protocols for Genetically Engineered Mice.
Limaye A; Cho K; Hall B; Khillan JS; Kulkarni AB
Curr Protoc; 2023 Nov; 3(11):e929. PubMed ID: 37984376
[TBL] [Abstract][Full Text] [Related]
26. RCAS-TVA in the mammary gland: an in vivo oncogene screen and a high fidelity model for breast transformation?
Du Z; Li Y
Cell Cycle; 2007 Apr; 6(7):823-6. PubMed ID: 17377492
[TBL] [Abstract][Full Text] [Related]
27. Intraductal Delivery and X-ray Visualization of Ethanol-Based Ablative Solution for Prevention and Local Treatment of Breast Cancer in Mouse Models.
Kenyon E; Zaluzec EK; Powell K; Volk M; Chakravarty S; Hix J; Arora R; Westerhuis JJ; Kiupel M; Shapiro EM; Sempere LF
J Vis Exp; 2022 Apr; (182):. PubMed ID: 35435915
[TBL] [Abstract][Full Text] [Related]
28. Genetically engineered mouse models for studying radiation biology.
Castle KD; Chen M; Wisdom AJ; Kirsch DG
Transl Cancer Res; 2017 Jul; 6(Suppl 5):S900-S913. PubMed ID: 30733931
[TBL] [Abstract][Full Text] [Related]
29. Pancreatic cancer modeling using retrograde viral vector delivery and in vivo CRISPR/Cas9-mediated somatic genome editing.
Chiou SH; Winters IP; Wang J; Naranjo S; Dudgeon C; Tamburini FB; Brady JJ; Yang D; Grüner BM; Chuang CH; Caswell DR; Zeng H; Chu P; Kim GE; Carpizo DR; Kim SK; Winslow MM
Genes Dev; 2015 Jul; 29(14):1576-85. PubMed ID: 26178787
[TBL] [Abstract][Full Text] [Related]
30. p53 Loss synergizes with estrogen and papillomaviral oncogenes to induce cervical and breast cancers.
Shai A; Pitot HC; Lambert PF
Cancer Res; 2008 Apr; 68(8):2622-31. PubMed ID: 18413729
[TBL] [Abstract][Full Text] [Related]
31. The challenges of modeling hormone receptor-positive breast cancer in mice.
Özdemir BC; Sflomos G; Brisken C
Endocr Relat Cancer; 2018 May; 25(5):R319-R330. PubMed ID: 29563191
[TBL] [Abstract][Full Text] [Related]
32. Lentivirus-mediated oncogene introduction into mammary cells in vivo induces tumors.
Siwko SK; Bu W; Gutierrez C; Lewis B; Jechlinger M; Schaffhausen B; Li Y
Neoplasia; 2008 Jul; 10(7):653-62, 1 p following 662. PubMed ID: 18592025
[TBL] [Abstract][Full Text] [Related]
33. Generation of immunocompetent somatic glioblastoma mouse models through in situ transformation of subventricular zone neural stem cells.
Clements M; Simpson Ragdale H; Garcia-Diaz C; Parrinello S
STAR Protoc; 2024 Mar; 5(1):102928. PubMed ID: 38430519
[TBL] [Abstract][Full Text] [Related]
34. Genome-Wide CRISPR Screen Identifies Regulators of Mitogen-Activated Protein Kinase as Suppressors of Liver Tumors in Mice.
Song CQ; Li Y; Mou H; Moore J; Park A; Pomyen Y; Hough S; Kennedy Z; Fischer A; Yin H; Anderson DG; Conte D; Zender L; Wang XW; Thorgeirsson S; Weng Z; Xue W
Gastroenterology; 2017 Apr; 152(5):1161-1173.e1. PubMed ID: 27956228
[TBL] [Abstract][Full Text] [Related]
35. Signal transduction in transgenic mouse models of human breast cancer--implications for human breast cancer.
Marcotte R; Muller WJ
J Mammary Gland Biol Neoplasia; 2008 Sep; 13(3):323-35. PubMed ID: 18651209
[TBL] [Abstract][Full Text] [Related]
36. Introduction of oncogenes into mammary glands in vivo with an avian retroviral vector initiates and promotes carcinogenesis in mouse models.
Du Z; Podsypanina K; Huang S; McGrath A; Toneff MJ; Bogoslovskaia E; Zhang X; Moraes RC; Fluck M; Allred DC; Lewis MT; Varmus HE; Li Y
Proc Natl Acad Sci U S A; 2006 Nov; 103(46):17396-401. PubMed ID: 17090666
[TBL] [Abstract][Full Text] [Related]
37. Inducible Genome Editing with Conditional CRISPR/Cas9 Mice.
Katigbak A; Robert F; Paquet M; Pelletier J
G3 (Bethesda); 2018 May; 8(5):1627-1635. PubMed ID: 29519936
[TBL] [Abstract][Full Text] [Related]
38. Practical use of advanced mouse models for lung cancer.
Safari R; Meuwissen R
Methods Mol Biol; 2015; 1267():93-124. PubMed ID: 25636466
[TBL] [Abstract][Full Text] [Related]
39. Recent Advances in the Production of Genome-Edited Rats.
Sato M; Nakamura S; Inada E; Takabayashi S
Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269691
[TBL] [Abstract][Full Text] [Related]
40. SEMMs: Somatically Engineered Mouse Models. A New Tool for
Lima A; Maddalo D
Front Oncol; 2021; 11():667189. PubMed ID: 33968774
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
